Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Eleni Efstathiou is a medical oncologist and Associate Professor in the Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. She received her MD and PhD at the National and Kapodistrian University of Athens School of Medicine in Athens, Greece. Dr. Efsthathiou then went on to complete a post-doctoral fellowship at MD Anderson.
Dr. Efstathiou focuses on tissue-based translational research in prostate cancer and has established two labs dedicated to this work—the Stanford Alexander tissue and derivatives laboratory and the Eckstein laboratory that centers on the interaction with clinic and patient and collection of tissue and other research samples. Her work has included exploring the impact of novel therapeutic agents on the tumor microenvironment and associating with pretreatment molecular characteristics that have significantly impacted research practices and promoted precision therapy pursuit.
Dr. Efstathiou has received both the Young Investigator Award and the Career Development Award from the Prostate Cancer Foundation. She has been published in numerous peer-reviewed medical journals including Lancet Oncology, European Eurology and many others.
Dr. Efsthathiou is dedicated to prostate cancer research and is considered an international expert in spearheading and forging therapy development strategies in prostate cancer. She’s currently continuing her research to help classify the disease and target appropriately in the search for a cure for prostate cancer.